A golden cross formed in ZTS stock price chart last week, where the 50-day moving average surpassed the 200-day line, signaling extended bullish potential. Zoetis is currently trading at a 24.86x PE multiple. For context, the average PE ratio for the global Pharmaceuticals sector sits at 19.77x, and Zoetis’ closest peers average around 15.47x. On the surface, this premium might make Zoetis look expensive compared to its industry and peers. ZTS is a Zacks Rank #3 (Hold) stock, with a Momentum Style Score of B and VGM Score of B. Shares are up 3.2% over the past one week and up 7.4% over the past four weeks. ZTS has lost 1.4% in the last one-year period as well. Looking at trading volume, an average of 3,002,777.25 shares exchanged hands over the last 20 trading days. Analysts note ZTS stock price resilience against macro headwinds like interest rate uncertainty, underpinned by non-cyclical demand in veterinary pharma solutions.
